These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10858632)

  • 1. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life.
    Voruganti L; Cortese L; Oyewumi L; Cernovsky Z; Zirul S; Awad A
    Schizophr Res; 2000 Jun; 43(2-3):135-45. PubMed ID: 10858632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study.
    Voruganti L; Cortese L; Owyeumi L; Kotteda V; Cernovsky Z; Zirul S; Awad A
    Schizophr Res; 2002 Oct; 57(2-3):201-8. PubMed ID: 12223251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation.
    Awad AG; Voruganti LN; Heslegrave RJ
    Qual Life Res; 1997 Jan; 6(1):21-6. PubMed ID: 9062438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine.
    Voruganti LP; Awad AG; Parker G; Forrest C; Usmani Y; Fernando ML; Senthilal S
    Schizophr Res; 2007 Nov; 96(1-3):146-55. PubMed ID: 17728106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' opinions of olanzapine and risperidone following long-term treatment: results from a cross-sectional survey.
    McGrath BM; Tempier RP
    Pharmacopsychiatry; 2005 Jul; 38(4):147-57. PubMed ID: 16025416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of atypical antipsychotics on quality of life in patients with schizophrenia.
    Awad AG; Voruganti LN
    CNS Drugs; 2004; 18(13):877-93. PubMed ID: 15521791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective experience and mental side-effects of antipsychotic treatment.
    Gerlach J; Larsen EB
    Acta Psychiatr Scand Suppl; 1999; 395():113-7. PubMed ID: 10225340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in schizophrenia on conventional versus atypical antipsychotic medication: a comparative cross-sectional study.
    Mortimer AM; Al-Agib AO
    Int J Soc Psychiatry; 2007 Mar; 53(2):99-107. PubMed ID: 17472084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients.
    Franz M; Lis S; Plüddemann K; Gallhofer B
    Br J Psychiatry; 1997 May; 170():422-5. PubMed ID: 9307690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
    Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
    Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice: a naturalistic comparative study.
    Ritsner M; Gibel A; Perelroyzen G; Kurs R; Jabarin M; Ratner Y
    J Clin Psychopharmacol; 2004 Dec; 24(6):582-91. PubMed ID: 15538118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia.
    Voruganti LN; Awad AG
    Schizophr Res; 2002 Jul; 56(1-2):37-46. PubMed ID: 12084418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population.
    Yamashita H; Mori K; Nagao M; Okamoto Y; Morinobu S; Yamawaki S
    J Clin Psychiatry; 2004 Nov; 65(11):1525-30. PubMed ID: 15554767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE study.
    Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1078-85. PubMed ID: 24726579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flupenthixol versus risperidone: subjective quality of life as an important factor for compliance in chronic schizophrenic patients.
    Hertling I; Philipp M; Dvorak A; Glaser T; Mast O; Beneke M; Ramskogler K; Saletu-Zyhlarz G; Walter H; Lesch OM
    Neuropsychobiology; 2003; 47(1):37-46. PubMed ID: 12606844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.
    Freudenreich O; Cather C; Evins AE; Henderson DC; Goff DC
    J Clin Psychiatry; 2004 Oct; 65(10):1372-6. PubMed ID: 15491241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
    Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
    J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia.
    Kim JH; Kim SY; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):301-5. PubMed ID: 16309807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.